Combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma
<p><strong>Background</strong></p> <p>Asthma affects 350 million people worldwide including 45% to 70% with mild disease. Treatment is mainly with inhalers containing beta₂‐agonists, typically taken as required to relieve bronchospasm, and inhaled corticosteroids (ICS)...
Päätekijät: | Crossingham, I, Turner, S, Ramakrishnan, S, Fries, A, Gowell, M, Yasmin, F, Richardson, R, Webb, P, O'Boyle, E, Hinks, TSC |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
Wiley
2021
|
Samankaltaisia teoksia
-
Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma
Tekijä: Crossingham, I, et al.
Julkaistu: (2020) -
Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review
Tekijä: Crossingham, I, et al.
Julkaistu: (2021) -
Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids while on monoclonal antibody therapy: protocol for a prospective observational study (BOOST)
Tekijä: Howell, I, et al.
Julkaistu: (2023) -
A proof-of-concept scale to predict asthma attacks: the OxfoRd Asthma attaCk risk ScaLE (ORACLE)
Tekijä: Couillard, S, et al.
Julkaistu: (2021) -
Azithromycin for mild-to-moderate COVID-19 - Authors' reply
Tekijä: Hinks, TSC
Julkaistu: (2021)